TABLE 4.
Sociodemographic and Clinical Characteristics of Patients Who Responded to the Screening Assessment (n = 3521)
| Characteristic | Mean | SD |
|---|---|---|
|
| ||
| Age, y | 57.15 | 13.39 |
| Time since diagnosis, y | 2.59 | 3.67 |
| BMI, kg/m2 | 27.82 | 6.44 |
| Charlson Comorbidity Index | 5.41 | 2.76 |
| Characteristic | No. | % |
| Sex: female | 2398 | 68.11 |
| Ethnicity | ||
| Hispanic | 143 | 4.06 |
| Not Hispanic | 3133 | 88.98 |
| Unable to answer or declined | 245 | 6.96 |
| Race | ||
| Asian | 124 | 3.52 |
| Black or African American | 246 | 6.99 |
| White | 2681 | 76.14 |
| Other | 217 | 6.16 |
| Missing | 253 | 7.19 |
| Cancer type | ||
| Hematologic malignancies (lymphoma and leukemia) | 1057 | 30.02 |
| Breast | 787 | 22.35 |
| Gynecologic malignancies | 545 | 15.48 |
| Gastrointestinal malignancies | 289 | 8.21 |
| Sarcoma (soft tissue and bone) | 65 | 1.85 |
| Lung and other thoracic malignancies | 142 | 4.03 |
| Other or unspecified malignancies | 136 | 3.86 |
| Prostate | 58 | 1.65 |
| Skin | 68 | 1.93 |
| Other genitourinary | 61 | 1.73 |
| Central nervous system | 54 | 1.53 |
| Head and neck | 32 | 0.91 |
| Thyroid and other endocrine glands | 13 | 0.37 |
| Missing | 214 | 6.08 |
Abbreviations: BMI, body mass index; SD, standard deviation.